Flu Clinical Trials

Find Flu Clinical Trials Near You

The Impacts of Adverse Provider Conditions on Medical Decision-Making and Patient Care

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Other, Biological
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

This is a randomized, double-blind clinical trial involving emergency medicine and internal medicine healthcare providers as participants. The intervention involves the administration of the seasonal influenza vaccine or a saline placebo; this protocol is used in psychoneuro-immunology to simulate a state of mild illness. The primary aim is to examine whether acute inflammation induced by receiving the vaccine affects decision-making on standardized psychological reaction time tasks and questionnaires. Participants attend two laboratory sessions on consecutive days, receive either a seasonal influenza vaccine or a saline placebo at the first session, provide blood samples to measure inflammatory cytokines, and complete a series of standardized assessments of medical decision-making and social attitudes. Participants who received the placebo during the first session will receive the vaccine during the second session. Overall, the study is designed to examine how adverse provider conditions particularly acute inflammation, burnout, and concerns about one's own health affect provider judgments and healthcare-related decision-making. The primary hypothesis is that providers experiencing greater adverse conditions at the time of research participation would have altered decision-making compared to those experiencing fewer adverse conditions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Healthcare providers currently employed in emergency medicine or internal medicine

• Must be one of the following: Resident, fellow, attending, or advanced practice provider (NP, PA)

• Individual is able to travel to the research site for sessions

• Has not had an acute viral or bacterial infection within the previous 14 days

• Has not taken an antiviral medication such as Tamiflu in the previous 48 hours

• Has not taken corticosteroids or immunosuppressants in the previous 30 days

Locations
United States
Arkansas
University of Arkansas for Medical Sciences
RECRUITING
Fayetteville
New Mexico
University of New Mexico Health Sciences Center
RECRUITING
Albuquerque
Virginia
Carilion Medical Center
RECRUITING
Roanoke
Contact Information
Primary
Anastasia Makhanova, PhD
ammakhan@uark.edu
479-575-8798
Time Frame
Start Date: 2026-09
Estimated Completion Date: 2027-12
Participants
Target number of participants: 210
Treatments
Experimental: Influenza Vaccine Injection
Receives the influenza vaccine at the end of Session 1
Placebo_comparator: Placebo Injection
Receives a saline placebo injection at the end of Session 1
Related Therapeutic Areas
Sponsors
Collaborators: University of New Mexico, The University of Texas Health Science Center at San Antonio, Carilion Clinic, National Institute on Minority Health and Health Disparities (NIMHD), University of Arkansas, Loma Linda University
Leads: University of Arkansas, Fayetteville

This content was sourced from clinicaltrials.gov